Alexander Hoekstra โ€” investor profile photo

Alexander Hoekstra

Co-Founder of the Rapid Deployment Vaccine Collaborative (RaDVaC), the world's first and fastest open source COVID-19 vaccine project.

๐Ÿ“ Greater Boston, United States๐Ÿ”„ Updated November 2026๐Ÿ’ผ 2 investments๐Ÿ“… 14 years investing๐Ÿ—“ Last invested Apr 2013๐• @upgrade_to_unlock
VC๐ŸŒ United States
2
Total investments
1
Early stage
1
Mid stage
0
Late stage
14y
Years active

Portfolio

2 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Core Board Member
Apr 2013
BOSLab is the DIYbio space of Boston. Our mission is to make science accessible to everyone through outreach, education and our DIY laboratory. At BOSLab you can: - learn from molecular biology to synthetic biology, by doing real things - understand why and how biotechnologies are shaping our future - teach and share your own science with awesome people full of passion
mid stageBiotechnology
Co-Founder, Board Member
Dec 2012
Building a community of people, technology, and research to understand and bring an end to mental dis-ease.
early stage
Experience ยท 5 entries
All (5)
Investments (1)
Founder (2)
Board (1)
2020
Rapid Deployment Vaccine Collaborative (RaDVac)
Co-Founder, Scientist
Mar 2020
2013
Core Board Member
Apr 2013
BOSLab is the DIYbio space of Boston. Our mission is to make science accessible to everyone through outreach, education and our DIY laboratory. At BOSLab you can: - learn from molecular biology to synthetic biology, by doing real things - understand why and how biotechnologies are shaping our future - teach and share your own science with awesome people full of passion
mid stageBiotechnology
2012
Co-Founder, Board Member
Dec 2012
Building a community of people, technology, and research to understand and bring an end to mental dis-ease.
early stage
Partnerships & Community Operations
Aug 2012
The mission of TeloMe (pronounced "tella-me") is to bring affordable biomarker testing to everyone, with a particular focus on telomere length, which has emerged as potentially the single most powerful and modifiable predictor of current and future health. However, current technologies have many limitations and produced some contradictory and questionable results. For maximum affordability and accessibility, we have focused on saliva-based testing, and direct sample collection by mail and courier. TeloMe's suite of technologies provides accurate and reproducible measurement of telomere length in saliva or blood, allowing non-invasive and convenient collection of samples through the mail and in the clinic.
early stageBiotechnology
2011
JournalClub
Managing Partner
Apr 2011
Investor lists
Lists that match Alexander's portfolio